|Apperance||Pale Yellow Solid|
|Delivery time||12h after your payment|
|Packing||Discreet package for delivery guarantee!|
|Payment||Western Union, Money gram, T/T,Bitcoin|
What is Andarine (S4)?
Andarine (S4), developed by GTX Inc., for the treatment of muscle wasting, osteoporosis and BPH (prostate enlargement), belongs to the class of drugs called SARM selective androgen receptor modulators. Today, it is widely used and sold as a research chemical, athletes use these research chemicals, trying to gain all the advantages of strength and lean muscle growth without the addition of anabolic steroids to observe harmful side effects. In addition, orarine is also used as part of the steroid stack to improve the cycle without adding more side effects or aromatization.
How does it work?
Selective androgen receptor modulators (SARMS) bind to the androgen receptor and demonstration osteo (bone) and myo (muscular) anabolic activity.
Binding and activation of the Androgen receptor alters the expression of genes and amplified protein synthesis which ultimately builds muscle.
SARMS such as S4 can cause muscle growth in the same manner as steroids, regardless of testosterone and other anabolic steroids, SARMS (as nonsteroidal agents) do not produce the growth effect on prostate and other secondary sexual organs.
SARMS not only represent a new potential treatment option for a wide spectrum of conditions such as muscle wasting diseases (from age-related to AIDS or cancer-related), but they also have immense potential for muscle building for Bodybuilders, fitness and athletes.
Andarine S4 is a SARM that was developed for treatment of muscle wasting, osteoporosis and benign prostatic hypertrophy. S4 is effective in not only maintaining lean body mass, but increasing it while reducing reducing body fat.
It is less potent in both anabolic and androgenic effects than other SARMs Any reduces in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti- Androgenic drugs traditionally used for treatment of BPH.
Other hot-selling Sarms
|MK-2866 (Ostarine; Enobosarm; GTX-024; S-1)||1202044-20-9|
|GW501516 (Cardarine) (GSK-516) GW1516||317318-70-0|
|MK-677 (MK-0677; Ibutamoren; Ibutamoren; nutrobal; L 163,191; Ibutamoren mesylate; Crescendo)||159752-10-0|
|S4 (Andarine; GTX-007; Acetamidoxolutamide)||401900-40-1|